Skip to content

Author

Sheng-Nan Wu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Integrating Molecular and Imaging Insights: Ryanodine Receptor 2 (RyR2) Expression, CK18 Status, and Conventional MRI Findings in Pituitary Neuroendocrine Tumors

Ryanodine receptor 2 (RyR2) has been increasingly recognized as an important regulator in cancer biology. Previous studies demonstrate that RyR2 expression is associated with patient survival, although its precise role in tumorigenesis remains unclear. Elevated RyR2 expression has been linked to poorer survival outcome...

Monika Duseikaite-Vidike, Alvita Vilkeviciute-Petraite, Indrė Žoštautienė et al. · 0 citations
#software testing Open access Sep 2026

IL33 gene polymorphisms and circulating IL-33 levels in pituitary adenoma: a case–control study

Pituitary adenoma (PA) is common intracranial tumor in which inflammatory mechanisms may contribute to tumor development and progression. Interleukin-33 (IL-33), an immune-related cytokine, has been implicated in tumor-associated inflammation; however, its role in pituitary adenomas remains unclear. This study aime...

Lea Neuendorf, Alvita Vilkeviciute-Petraite, A. Tamasauskas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.